Roflumilast Tablet
Product Images NDC 59651-275

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 59651-275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Roflumilast Fig1)

Figure1 (Roflumilast Fig1)
A forest plot chart displaying the fold change in Cmax and AUC with 90% confidence intervals for Roflumilast and its N-oxide metabolite when taken with various drugs. It categorizes drug interactions with recommendations such as 'Use With Caution,' 'No Dose Adjustment,' or 'Not recommended,' and visually compares these effects relative to a reference.*
FDA Label Image

Package Label-principal Display Panel (500 mcg (30 Tablet Bottle))

Package Label-principal Display Panel (500 mcg (30 Tablet Bottle))
Roflumilast Tablets 500 mcg oral medication label from Aurobindo Pharma Limited showing a 30-tablet package. The label includes dosage strength (500 mcg), manufacturer details (Aurobindo Pharma USA, Inc.), storage instructions (20° to 25°C), and a barcode with NDC 59651-275-30. It also instructs the pharmacist to dispense the Medication Guide separately.*
FDA Label Image

Chemical Structure (Roflumilast Str)

Chemical Structure (Roflumilast Str)
Chemical structure diagram of roflumilast, showing its molecular arrangement with trifluoromethoxy, cyclopropylmethoxy, and chloropyridyl groups. The structure corresponds to the active ingredient roflumilast in the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.